---
figid: PMC8616345__cancers-13-05724-g003
figtitle: Advances in Immunotherapy and the TGFB Resistance Pathway in Metastatic
  Bladder Cancer
organisms:
- Homo sapiens
- Mus musculus
organisms_ner:
- Homo sapiens
pmcid: PMC8616345
filename: cancers-13-05724-g003.jpg
figlink: /pmc/articles/PMC8616345/figure/cancers-13-05724-f003/
number: F3
caption: TGF-β signaling pathway drives immune cell exclusion. (A) Active TGF-β signaling
  pathway drives immune cell exclusion. (B) Inactive TGF-β signaling pathway drives
  a T cell-inflamed tumor phenotype (adapted from “Cold vs. Hot tumors”, by BioRender.com
  (2021). Retrieved from https://app.biorender.com/biorender-templates, accessed on
  14 October 2021).
papertitle: Advances in Immunotherapy and the TGF-β Resistance Pathway in Metastatic
  Bladder Cancer.
reftext: David J. Benjamin, et al. Cancers (Basel). 2021 Nov;13(22):5724.
year: '2021'
doi: 10.3390/cancers13225724
journal_title: Cancers
journal_nlm_ta: Cancers (Basel)
publisher_name: MDPI
keywords: urothelial carcinoma | bladder cancer | immunotherapy | TGF-β resistance
  pathway
automl_pathway: 0.5533915
figid_alias: PMC8616345__F3
figtype: Figure
redirect_from: /figures/PMC8616345__F3
ndex: ''
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC8616345__cancers-13-05724-g003.html
  '@type': Dataset
  description: TGF-β signaling pathway drives immune cell exclusion. (A) Active TGF-β
    signaling pathway drives immune cell exclusion. (B) Inactive TGF-β signaling pathway
    drives a T cell-inflamed tumor phenotype (adapted from “Cold vs. Hot tumors”,
    by BioRender.com (2021). Retrieved from https://app.biorender.com/biorender-templates,
    accessed on 14 October 2021).
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - TGFB1
  - TGFB2
  - TGFB3
  - CD8A
  - CD8B
  - PDCD1
  - RPL17
  - RPL17-C18orf32
---
